Scarica l'app Stockscreener
12.45
0.93%
0.095
Panoramica
Notizia
Cronologia dei prezzi
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$12.35
Aprire:
$12.36
Volume 24 ore:
60,845
Relative Volume:
0.54
Capitalizzazione di mercato:
$207.26M
Reddito:
$6.67M
Utile/perdita netta:
$-47.55M
Rapporto P/E:
-8.2967
EPS:
-1.5
Flusso di cassa netto:
$-17.44M
1 W Prestazione:
-0.28%
1M Prestazione:
+6.36%
6M Prestazione:
+2,338%
1 anno Prestazione:
+2,338%
Intervallo 1D:
$12.10
$12.65
Intervallo di 1 settimana:
$12.00
$12.87
Portata 52W:
$9.81
$21.40
Crescent Biopharma Inc Stock (CBIO) Company Profile
Nome
Crescent Biopharma Inc
Settore
Industria
Telefono
617-430-5595
Indirizzo
300 FIFTH AVENUE, WALTHAM, CA
Confronta CBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBIO
Crescent Biopharma Inc
|
12.43 | 207.26M | 6.67M | -47.55M | -17.44M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.34 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.69 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.32 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
835.55 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.65 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | Jefferies | Buy |
| 2025-08-11 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-14 | Iniziato | Wedbush | Outperform |
| 2025-06-25 | Iniziato | Stifel | Buy |
| 2025-03-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-11 | Iniziato | Noble Capital Markets | Outperform |
| 2024-07-26 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-22 | Iniziato | CapitalOne | Overweight |
| 2021-11-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-04-29 | Ripresa | Stephens | Overweight |
| 2021-02-10 | Iniziato | Piper Sandler | Overweight |
| 2020-05-21 | Iniziato | Raymond James | Outperform |
| 2019-11-14 | Iniziato | ROTH Capital | Buy |
| 2019-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2019-08-05 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | Downgrade | SunTrust | Buy → Hold |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-01-04 | Iniziato | Oppenheimer | Outperform |
| 2018-12-18 | Iniziato | H.C. Wainwright | Buy |
| 2018-02-12 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Reiterato | Chardan Capital Markets | Buy |
| 2017-12-08 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Iniziato | Chardan Capital Markets | Buy |
| 2017-06-06 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-07-26 | Iniziato | SunTrust | Buy |
| 2016-06-30 | Iniziato | Rodman & Renshaw | Buy |
| 2015-03-17 | Reiterato | Stifel | Buy |
Mostra tutto
Crescent Biopharma Inc Borsa (CBIO) Ultime notizie
Crescent Biopharma, Inc. to Present Preclinical Data for CR-001, a PD-1 X VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer's 40th Annual Meeting - MarketScreener
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stockEarnings Risk Summary & Growth Focused Stock Reports - newser.com
Crescent Biopharma (NASDAQ:CBIO) Stock Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stockEarnings Recap Report & Long-Term Safe Investment Ideas - newser.com
Crescent BiopharmaLighting The Path To The Next Wave Of Cancer Therapies? - RTTNews
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickTrade Volume Summary & Verified Swing Trading Watchlist - newser.com
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetration2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Retail Surge: Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Price Swings & Reliable Price Breakout Alerts - Trung tâm Dự báo KTTV quốc gia
Moving Averages: Can Crescent Biopharma Inc. (GKO0) stock stage a strong rebound this quarter2025 Performance Recap & Stepwise Trade Signal Implementation - Trung tâm Dự báo KTTV quốc gia
TANG CAPITAL MANAGEMENT LLC Increases Stake in Crescent Biopharm - GuruFocus
GlycoMimetics skyrockets on buyout deal - MSN
Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN
Will Crescent Biopharma Inc. (GKO0) stock benefit from Fed rate cutsJuly 2025 Update & Safe Entry Zone Identification - newser.com
Short Interest in Crescent Biopharma, Inc. (NASDAQ:CBIO) Grows By 103.8% - MarketBeat
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives $25.60 Consensus Target Price from Analysts - Defense World
Will Crescent Biopharma Inc. (GKO0) stock hit Wall Street targetsJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Crescent Biopharma Inc Azioni (CBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.86%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):